Literature DB >> 11822969

Vascular inflammation as a therapeutic target for prevention of cardiovascular disease.

Luther T Clark1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11822969     DOI： 10.1007/s11883-002-0027-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  39 in total

1.  Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Authors:  J B Muhlestein; J L Anderson; J F Carlquist; K Salunkhe; B D Horne; R R Pearson; T J Bunch; A Allen; S Trehan; C Nielson
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 2.  Multiple signals converging on NF-kappaB.

Authors:  F Mercurio; A M Manning
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

3.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

4.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

5.  Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay.

Authors:  M Feldman; I Jialal; S Devaraj; B Cryer
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

Review 6.  Current perspective on the use of angiotensin-converting enzyme inhibitors in the management of coronary (atherosclerotic) artery disease.

Authors:  J W Cheng; M N Ngo
Journal:  Ann Pharmacother       Date:  1997-12       Impact factor: 3.154

7.  Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.

Authors:  S Navalkar; S Parthasarathy; N Santanam; B V Khan
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

Review 8.  Atherosclerotic plaque rupture: emerging insights and opportunities.

Authors:  J Plutzky
Journal:  Am J Cardiol       Date:  1999-07-08       Impact factor: 2.778

9.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

10.  Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

Authors:  M Aikawa; E Rabkin; Y Okada; S J Voglic; S K Clinton; C E Brinckerhoff; G K Sukhova; P Libby
Journal:  Circulation       Date:  1998-06-23       Impact factor: 29.690
View more
  2 in total

1.  Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis.

Authors:  Yong Woo Lee; Paul H Kim; Won Hee Lee; Anjali A Hirani
Journal:  Biomol Ther (Seoul)       Date:  2010-04       Impact factor: 4.634

2.  Effect of Gastrodia elata on tumor necrosis factor-alpha-induced matrix metalloproteinase activity in endothelial cells.

Authors:  Yun Jung Lee; Sun Mi Hwang; Dae Gill Kang; Jin Sook Kim; Ho Sub Lee
Journal:  J Nat Med       Date:  2009-08-12       Impact factor: 2.343
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.